A phase 1 trial of a retinoic acid receptor beta agonist for the treatment of spinal cord injury

Project: Research

Project Details

Effective start/end date1/02/201830/09/2021

Collaborative partners

  • King's College London (lead)
  • University of Cambridge (Collaborating partner)
  • University of Surrey (Collaborating partner)
  • University of Oxford (Collaborating partner)


  • MRC Medical Research Council: £1,795,160.00
  • MRC Medical Research Council: £882,057.70